varenicline has been researched along with Affective Disorders in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anthenelli, RM; Benowitz, NL; Evins, AE; Krishen, A; Lawrence, D; Maravic, MC; McRae, T; Russ, C; St Aubin, L; West, R | 1 |
Clyde, MJ; Els, C; Pipe, AL; Reid, RD; Tulloch, HE | 1 |
Muheim, L | 1 |
Catz, SL; Deprey, M; Jack, L; Javitz, H; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM | 1 |
Mambourg, SE; Nelson, LA; Purvis, TL | 1 |
Blendy, JA; Castellano, LM; Turner, JR | 1 |
Chen, MC; Jeang, SY; Liu, ME; Peng, SL; Tsai, SJ; Tsai, YL; Wu, SL; Yang, ST | 1 |
1 review(s) available for varenicline and Affective Disorders
Article | Year |
---|---|
Varenicline use in patients with mental illness: an update of the evidence.
Topics: Benzazepines; Evidence-Based Medicine; Humans; Limbic System; Mental Disorders; Mood Disorders; Patient Education as Topic; Quinoxalines; Smoking; Smoking Cessation; Suicide; Treatment Outcome; Varenicline | 2010 |
3 trial(s) available for varenicline and Affective Disorders
Article | Year |
---|---|
Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES.
Topics: Adult; Age Factors; Anxiety Disorders; Bupropion; Double-Blind Method; Ethnicity; Female; Humans; International Cooperation; Male; Middle Aged; Mood Disorders; Prognosis; Psychotic Disorders; Psychotropic Drugs; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Treatment Outcome; United States; Varenicline | 2018 |
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bupropion; Cohort Studies; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Nicotine; Smoking Cessation; Varenicline; Young Adult | 2016 |
Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline.
Topics: Adult; Affect; Benzazepines; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mood Disorders; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2009 |
3 other study(ies) available for varenicline and Affective Disorders
Article | Year |
---|---|
The Quit Experience and Concerns of Smokers With Psychiatric Illness.
Topics: Female; Humans; Male; Middle Aged; Mood Disorders; Motivation; Nicotinic Agonists; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices; Varenicline | 2016 |
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
Topics: Animals; Anxiety; Azetidines; Behavior, Animal; Benzazepines; Chimera; Depression; Drug Partial Agonism; Male; Mice; Mood Disorders; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Varenicline | 2010 |
Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia.
Topics: Adult; Analysis of Variance; Benzazepines; Cognition; Humans; Male; Middle Aged; Mood Disorders; Neuropsychological Tests; Nicotinic Agonists; Psychiatric Status Rating Scales; Quinoxalines; Regression Analysis; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline | 2011 |